» Articles » PMID: 38627233

Comparative Efficacy of Exercise, Diet And/or Pharmacological Interventions on BMI, Ovulation, and Hormonal Profile in Reproductive-aged Women with Overweight or Obesity: a Systematic Review and Network Meta-analysis

Abstract

Background: The increasing prevalence of obesity worldwide poses a significant threat to reproductive function owing, in part, to hormonal disturbances caused by negative feedback between excess adiposity and the hypothalamic-pituitary-ovarian axis. Consequently, finding the most appropriate strategies to lose weight and improve ovulation in women with overweight or obesity is a clinically relevant matter that needs to be investigated. A comprehensive comparison of the independent and combined efficacy of lifestyle and/or pharmacological interventions on BMI, ovulation, and hormonal profile in women with overweight or obesity at risk of anovulatory infertility would facilitate improving fertility strategies in this population.

Objective And Rationale: This study aimed to evaluate the comparative efficacy of exercise, diet, and pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity.

Search Methods: A systematic review was performed by searching PubMed, Scopus, Web of Science, PsycINFO, and Cochrane Library up to 14 December 2023, for randomized controlled trials assessing the effects of exercise, diet and/or pharmacological interventions (i.e. weight-lowering drugs or ovulation inducers) on BMI, ovulation, and/or hormonal profile in reproductive-aged women with overweight or obesity. We performed frequentist random-effect network meta-analyses and rated the certainty of the evidence. The primary outcomes were BMI and ovulation rate, and the secondary outcomes were serum reproductive hormone levels (gonadotrophins, androgens, or oestrogens). We performed sensitivity analyses, including the studies that only involved women with PCOS.

Outcomes: Among 1190 records screened, 148 full texts were assessed for eligibility resulting in 95 trials (9910 women), of which 53% presented a high or unclear risk of bias. The network meta-analyses revealed that, compared to control: diet combined with weight-lowering drugs (mean difference (MD) -2.61 kg/m2; 95% CI -3.04 to -2.19; τ2 = 0.22) and adding exercise (MD -2.35 kg/m2; 95% CI -2.81 to -1.89; τ2 = 0.22) led to the greatest decrease in BMI; exercise combined with diet and ovulation inducers (risk ratio (RR) 7.15; 95% CI 1.94-26.40; τ2 = 0.07) and exercise combined with diet and weight-lowering drugs (RR 4.80; 95% CI 1.67-13.84; τ2 = 0.07) produced the highest increase in ovulation rate; and exercise combined with diet and weight-lowering drugs was the most effective strategy in reducing testosterone levels (standardized mean difference (SMD) -2.91; 95% CI -4.07 to -1.74; τ2 = 2.25), the third most effective strategy in increasing sex hormone-binding globulin levels (SMD 2.37; 95% CI 0.99-3.76; τ2 = 2.48), and it was coupled with being ranked first in terms of free androgen index reduction (SMD -1.59; 95% CI -3.18 to 0.01; τ2 = 1.91). The surface under the cumulative ranking curve scores suggested that: diet combined with weight-lowering drugs is the strategy most likely (94%) to produce the highest BMI reduction; and exercise combined with diet and ovulation inducers is the strategy most likely (89%) to produce the highest ovulation rate improvement. The sensitivity analyses, which exclusively included studies involving women diagnosed with PCOS, were consistent with the results presented above.

Wider Implications: Overall, the findings of this network meta-analysis indicate that the combination of exercise, diet, and pharmacological interventions is effective for weight loss, improving ovulation, and normalizing the androgen levels of women with overweight or obesity. Although higher quality studies are needed, these results support that the optimal treatment strategy for women with overweight or obesity wishing to conceive must consider exercise, diet, and pharmacological interventions during the shared decision-making process.

Citing Articles

Menstrual and sexual functions in female patients after sleeve gastrectomy due to obesity: obesity and sexual function.

Uzelli Simsek H, Varol E, Guler S, Simsek T, Sahin E, Canturk N Arch Gynecol Obstet. 2025; .

PMID: 39909881 DOI: 10.1007/s00404-025-07966-z.


Evaluating the effects of time-restricted eating on overweight and obese women with polycystic ovary syndrome: A randomized controlled trial study protocol.

Liu H, Shangguan F, Liu F, Guo Y, Yu H, Li H PLoS One. 2025; 20(1):e0316333.

PMID: 39787136 PMC: 11717230. DOI: 10.1371/journal.pone.0316333.


Gaps in knowledge regarding the diagnostic criteria and management of PCOS in Germany: An anonymous web-based survey.

Hofmann K, Oehler M, Ruckes C, Dionysopoulou A, Stewen K, Schiestl L Heliyon. 2024; 10(22):e40431.

PMID: 39641034 PMC: 11617859. DOI: 10.1016/j.heliyon.2024.e40431.


The Molecular Link between Obesity and the Endometrial Environment: A Starting Point for Female Infertility.

Gonnella F, Konstantinidou F, Donato M, Gatta D, Peserico A, Barboni B Int J Mol Sci. 2024; 25(13).

PMID: 38999965 PMC: 11241599. DOI: 10.3390/ijms25136855.

References
1.
Shukla K, Chambial S, Dwivedi S, Misra S, Sharma P . Recent scenario of obesity and male fertility. Andrology. 2014; 2(6):809-18. DOI: 10.1111/andr.270. View

2.
Froment P, Touraine P . Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS). PPAR Res. 2007; 2006:73986. PMC: 1779579. DOI: 10.1155/PPAR/2006/73986. View

3.
Kort J, Winget C, Kim S, Lathi R . A retrospective cohort study to evaluate the impact of meaningful weight loss on fertility outcomes in an overweight population with infertility. Fertil Steril. 2014; 101(5):1400-3. DOI: 10.1016/j.fertnstert.2014.01.036. View

4.
Nybacka A, Carlstrom K, Fabri F, Hellstrom P, Linden Hirschberg A . Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial. Fertil Steril. 2013; 100(4):1096-102. DOI: 10.1016/j.fertnstert.2013.06.030. View

5.
Bazzi A, Schon S . Beyond diet and exercise: another option for patients with obesity and polycystic ovary syndrome?. Fertil Steril. 2022; 118(2):382-383. DOI: 10.1016/j.fertnstert.2022.06.001. View